Recent advances in opto-electronics have enabled the development of an equipment detectable of non-visible, extremely weak light emitted from organic and inorganic materials at the levels of approximately 10
-6 of the minimally visible light.
In this extremely faint light intensity region, photons emitted do not compose a continuous flow and are rather scattered. These photons are better expressed as the number of the photons counted per unit of time in the measurement.
Application of the equipment in the assessment of ultraweak chemiluminescence in biological and medical fields has been now revealing several interesting findings and playing a role in the understanding of basic process of aging and of causes and consequences of diseases including carcinogenesis.
Weak light emissions from biological and chemical substances, like those seen in the reactions of luciferin-luciferase of firefly and of luminol, have been long since known. These phenomena are called bioluminescence and chemiluminescence, respectively, though the fundamental process underlying in both phenomena is the same and of the photon emission in the transition of an excited state of molecule to its basal state.
Among those weak light emitting phenomena, extremely weak, non-visible light emissions are sometimes described as extraweak chemiluminescence or ultra-weak chemilumenescence.
Singlet oxygen, one of active oxygen species, causes chemiluminescence. The transitions of the various excited states of siglet oxygen molecules to the basal triplet state accompany photon emissions. This nature favors the detection of siglet oxygen in biological samples, though precise causion is needed as the light emitting excited molecular species are not only siglet oxygen in biological materials.
In the present studies, ultra-weak chemiluminescence of human blood has been estimated in both healthy and diseased subjects.
Plasma samples of diabetic patients showed higher light emission than those of healthy subjects. The magnitudes of the increases in the ultra-weak chemilumenscence of the plasma of diabetic subjects were approximately twice of the healthy ones.
Plasma smaples of the patients with liver diseases also gave higher levels of light emission of various magnitudes. Plasma samples of the patients with hyperbilirubinemia like obstructive jaundice showed extraordinarily high light emission that increased gradually with time. Scavenger experiments and analysis of ultra-weak chemiluminescence specturm of the highly light emitting plasma indicated the contribution of singlet oxygen in the photon emitting phenomenon.
Healthy smoker's blood samples also showed higher light emission levels. These increases returned to the nonsmoker's levels by the cessation of smoking within 24 hours. Cigarette smoke itself was found to possess very high photon emitting property.
The light emission of the cigarette smoke absorbed into dimethyl sulfoxide was found to require the presence of molecular oxygen. Spectral analysis and scavenger experiments of this absorbed cigarette smoke lead to the indication that singlet oxygen is involved in this light emission of cigarette smoke.
Free redicals and active oxygens are of interest in the consideration of aging process and mechanisms of diseases, but are not easy to handle in clinical laboratory. The detection of singlet oxygen using ultra-weak cheiluminescence is easier. Several instances of the actual measurements of ultra-weak chemiluminescence are presented.
View full abstract